Histosurgical mapping of endoscopic endonasal surgery of sinonasal tumours to improve radiotherapy guidance.

Cancer Chirurgie Chirurgie endonasale endoscopique Endoscopic endonasal surgery Marge chirurgicale Margins Nasosinusienne Radiotherapy Radiothérapie Sinonasal

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272

Informations de publication

Date de publication:
May 2022
Historique:
received: 03 02 2021
revised: 21 05 2021
accepted: 01 06 2021
pubmed: 28 6 2021
medline: 21 5 2022
entrez: 27 6 2021
Statut: ppublish

Résumé

Endoscopic endonasal surgery (EES) is becoming a standard for most malignant sinonasal tumours. Margin analysis after piecemeal resection is complex and optimally relies on accurate histosurgical mapping. Postoperative radiotherapy may be adapted based on margin assessment mapping to reduce the dose to some sinonasal subvolumes. We assessed the use of histosurgical mapping by radiation oncologists (RO). A French practice survey was performed across 29 ENT expert RO (2 did not answer) regarding integration of information on EES, as well as quality of operative and pathology reportsto refine radiotherapy planning after EES. This was assessed through an electronic questionnaire. EES was ubiquitously performed in France. Operative and pathology reports yielded accurate description of EES samples according to 66.7% of interviewed RO. Accuracy of margin assessment was however insufficient according to more than 40.0% of RO. Additional margins/biopsies of the operative bed were available in 55.2% (16/29) of the centres. In the absence of additional margins, quality of resection after EES was considered as microscopically incomplete in 48.3% or dubious in 48.3% of RO. As performed, histosurgical mapping allowed radiotherapy dose and volumes adaptation according to 26.3% of RO only. Standardized histosurgical mapping with margin and additional margin analysis could be more systematic. Advantages of accurate EES reporting could be dose painting radiotherapy to further decrease morbidity in sinonasal tumours.

Identifiants

pubmed: 34175228
pii: S1278-3218(21)00113-X
doi: 10.1016/j.canrad.2021.06.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

440-444

Informations de copyright

Copyright © 2021 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

T Leleu (T)

Department of radiation oncology, centre François-Baclesse, Caen, France.

V Bastit (V)

Department of surgery, centre François-Baclesse, Caen, France.

M Doré (M)

CAC, Nantes, France.

E Kammerer (E)

Department of radiation oncology, centre François-Baclesse, Caen, France.

C Florescu (C)

Department of radiation oncology, centre François-Baclesse, Caen, France.

M Alfonsi (M)

ISC, Avignon, France.

I Troussier (I)

CHE, Nice, France.

R-J Bensadoun (RJ)

CHE, Nice, France.

J Biau (J)

CJP, Clermont-Ferrand, France.

E Blais (E)

AP-HP, Pitié-Salpêtrière, Paris, France.

A Coutte (A)

CHU, Amiens, France.

M Deberne (M)

CHU, Lyon, France.

N Wiazzane (N)

CAC, Nantes, France.

C Dupin (C)

CHU, Bordeaux, France.

J-C Faivre (JC)

Institut Lorraine, Nancy, France.

P Giraud (P)

CHU HEGP, Paris, France.

P Graff (P)

Oncopole, Toulouse, France.

S Guihard (S)

CPS, Strasbourg, France.

F Huguet (F)

CHU Tenon, Paris, France.

G Janoray (G)

CHU, Tours, France.

X Liem (X)

COL, Lille, France.

Y Pointreau (Y)

CJB, Le Mans, France.

S Racadot (S)

CLB, Lyon, France.

U Schick (U)

CHU, Brest, France.

S Servagi-Vernat (S)

Institut Godinot, Reims, France.

X S Sun (XS)

CHU, Besançon Montbéliard, France.

S Thureau (S)

CHB, Rouen, France.

J Villa (J)

CHU, Grenoble, France.

N Vulquin (N)

CGFL, Dijon, France.

S Wong (S)

CHU, Marseille, France.

V Patron (V)

Department of ENT surgery, CHU Caen, Caen, France.

J Thariat (J)

Department of radiation oncology, centre François-Baclesse, Caen, France; Unicaen, Normandie Université, Caen, France; GORTEC, France. Electronic address: jthariat@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH